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INTRODUCTION 
CNS PNET are infrequent in children and very rare in 
adults with an overall incidence of 0.26 per 100000 
person yeas reported by Central Brain Tumour Registry 
of the United States (CBTRUS).  
Overall it represents only 1.8% of all brain tumours. We 
hereby report a case of PNET arising from astrocytoma.  
CASE REPORT 
A 22 year old female unmarried patient presented with 
periodic attacks of black outs in 2010. Her CT scan 
revealed a brain SOL. CT scan (Figure 1) report showed 
a hypodense lesion non-enhancing about 8.6x6.7x5.8 cm 
in left temporo-parietal lobe.  
She was operated and histopathology report from three 
different academic pathology laboratories showed 
astrocytoma grade I, astrocytoma grade II, and diffuse 
fibrillary astrocytoma grade II. 
Postoperatively, the patient received cranial irradiation in 
31fr from 17/1/2011 to 25/2/2011. 
She remained asymptomatic for two years after which she 
developed pain and swelling at the operated site. In 
March 2013, CT scan revealed a recurrent non enhancing 
hypodense mass 5.6x4.6 cm in left fronto-parietal lobe 
causing midline shift (Figure 2). Patient was operated for 
second time. Pathology report showed diffuse fibrillary 
astrocytoma grade II. 
Patient’s symptoms progressed post-operatively and 
seven months later, MRI brain revealed a large 
7.0x7.0x6.6 cm non enhancing mass with evidence of 
solid and cystic component in the left temporal lobe, peri-
insular and parietal region (Figure 3) for which she was 
operated the third time in October, 2013. In post-op MRI, 
there was a residual enhancing intra axial mass 
5.7x7.2x5.2 cm in left temporal lobe with midline shift 
which was isointense on T1W and hyperintense on 
T2W& FLAIR sequence. Histopathology report showed 
glioblastoma with PNET. 
IHC was done and it was focally positive for neuron 
specific enolase and GFAP, negative for synaptophysin, 
and 60% positive for Ki67. 
Review of all previous biopsy blocks was done. 
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16/7/2010 - Diffuse astrocytoma grade II 
16/3/2013 - Glioblastoma grade IV 
30/10/2013 - Glioblastoma with Primitive 
Neuroectodermal tumour (PNET) 
Treatment in the form of cisplatin and etoposide based 
chemotherapy was started. After two chemotherapy 
cycles patients general condition deteriorated. A mass 
was seen protruding from the operative site. So palliative 
radiotherapy in order to relieve symptoms was started but 
the patient succumbed to death while on radiotherapy in 
Feb, 2014. 
 
Figure 1: CT scan report showed a hypodense lesion 
non-enhancing about 8.6x6.7x5.8 cm in left temporo-
parietal lobe. 
 
Figure 2: CT scan revealed a recurrent non enhancing 
hypodense mass 5.6x4.6 cm in left fronto-parietal lobe 
causing midline shift.  
 
Figure 3: MRI brain revealed a large 7.0x7.0x6.6 cm 
non enhancing mass with evidence of solid and cystic 
component in the left temporal lobe, peri-insular and 
parietal region. 
DISCUSSION 
The development of brain tumours in previously 
irradiated sites is a rare complication of cranial 
irradiation.
1,2 
Other possible risk factors for these 
secondary CNS tumours include younger age at 
irradiation, genetic predisposition to cancer, and genetic 
polymorphisms in certain metabolizing enzymes, such as 
thiopurine s-methyl-transferase.
2 
The most commonly 
reported histologic types of these tumours are the high-
grade gliomas, including glioblastomas and malignant 
astrocytomas.
1 
Nevertheless, cases of meningiomas, 
schwannomas, sarcomas, and PNETs arising in the CNS 
after cranial irradiation have also been described.
1-5 
Secondary PNETs have been reported in 11 patients at a 
mean of 8.5 years following a relatively low-dose 
prophylactic craniospinal irradiation (18-24 Gy) and 
intrathecal methotrexate for leukemia and lymphoma.
3 
In 
addition, a supratentorial secondary PNET was reported 
to occur in a patient with unilateral sporadic 
retinoblastoma 5 years after surgery, low-dose cranial 
irradiation (27.6 Gy), and intrathecal methotrexate.
4 
In 
these cases, the relative contribution of low-dose 
irradiation versus intrathecal methotrexate to the 
development of PNET is not clear.  
As compared to other cases reported in the past (Table1), 
in our case patient developed PNET within 2 years of 
cranial irradiation. 
 
Table 1: A review of previous case reports.  
Nr Sex/age Location Primary tumor 
Therapy 
(Gy/fractions) 
Latency to 
PNET 
Survival 
1 M 4 R occipital Oligodendroglioma grade II 44/20 29 months 36 months 
2 F 6 Cerebellar Pilocytic astrocytoma grade I 5000 c/25 11 years 11 months 
3 M 9 Cerebellar Malignant ependymoma 
3500 c/18 
2000 c/10 boost 
16 years 18 months 
4 M 37 Temporal Astrocytoma grade II 5000 c/25 5 years 6 months 
5 M 17 IV ventricle Astrocytoma grade II 
3400 c/17 
1600 c/8 boost 
2500 c/45 
18 years 12 months 
6 M 30 L parietal Astrocytoma grade II 54/30 10 years 9 months 
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PNETs describe a group of histologically similar 
neoplasms composed of embryonal small cells that may 
be undifferentiated or may have varying degrees of 
neuronal, glial, or mesenchymal differentiation. PNETs 
of the CNS include medulloblastomas, neuroblastomas, 
pineoblastomas, and ependymoblastomas.  
The exact mechanism of the development of PNETs after 
cranial irradiation is unknown, although it has been 
speculated to involve the persistence of a population of 
undifferentiated neuroepithelial cells in the CNS, as well 
as genetic mutations involving oncogenes such as K-
ras.
3,5
  
As it seems unlikely that cranial irradiation to be the 
cause of development of PNET in this case further 
research is required in this field to find the cause and 
PNET arising from astrocytoma may be considered a 
possibility.  
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